230.22港幣1.81(0.79%)
2024/05/03更新
績效 / 1月0.83%
3月1.09%
1年4.17%
晨星評等-
- 1.現金2.95%
- 2.股票21.18%
- 3.債券0.01%
- 4.其他75.86%
- 1.美國75.85%
- 2.歐洲不包含歐元區12.66%
- 3.歐元區4.57%
- 4.英國3.04%
- 5.日本0.80%
- 1.Eli Lilly and Co7.30%
- 2.Novo Nordisk A/S Class B7.09%
- 3.UnitedHealth Group Inc6.64%
- 4.AbbVie Inc4.78%
- 5.Merck & Co Inc4.51%
- 6.Boston Scientific Corp3.94%
- 7.Amgen Inc3.39%
- 8.AstraZeneca PLC3.27%
- 9.Abbott Laboratories2.96%
- 10.Danaher Corp2.82%
- 1.現金2.95%
- 2.股票21.18%
- 3.債券0.01%
- 4.其他75.86%
- 1.美國75.85%
- 2.歐洲不包含歐元區12.66%
- 3.歐元區4.57%
- 4.英國3.04%
- 5.日本0.80%
- 1.Eli Lilly and Co7.30%
- 2.Novo Nordisk A/S Class B7.09%
- 3.UnitedHealth Group Inc6.64%
- 4.AbbVie Inc4.78%
- 5.Merck & Co Inc4.51%
- 6.Boston Scientific Corp3.94%
- 7.Amgen Inc3.39%
- 8.AstraZeneca PLC3.27%
- 9.Abbott Laboratories2.96%
- 10.Danaher Corp2.82%